Leading pharmaceutical company engages X Ante to monitor portfolio of drugs for appearances in mass tort ads as early signal of litigation threat.
CASE STUDY #2: FINANCIAL PLANNING
Medical device manufacturer subject to sizable litigation monitors advertising to forecast litigation reserves for future litigation and settlement negotiations.
CASE STUDY #3: TRIAL ARGUMENTS
Products liability defense counsel utilizes X Ante reports to argue that jury pool contaminated by mass tort ad saturation and that aggressive advertising - not product defects - drove adverse event reporting and lawsuit filings.